Nektar to Announce Financial Results for the Second Quarter of 2009 on Tuesday, August 4, 2009, After Close of U.S.-Based Financi... ( SAN CARLOS Calif. July 31...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> BIOLOGY >> TECHNOLOGY

Nektar to Announce Financial Results for the Second Quarter of 2009 on Tuesday, August 4, 2009, After Close of U.S.-Based Financial Markets

Date:7/31/2009

SAN CARLOS, Calif., July 31 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the second quarter ended June 30, 2009 on Tuesday, August 4, 2009, after the close of U.S.-based financial markets. Howard Robin, president and chief executive officer, will host a conference call to review the results beginning at 5:00 p.m. Eastern Time (ET)/2:00 p.m. Pacific Time (PT).

The press release and a live audio-only Webcast of the conference call can be accessed through a link that is posted on the home page and Investor Relations section of the Nektar website: http://www.nektar.com. The web broadcast of the conference call will be available for replay through Wednesday, August 19, 2009.

To access the conference call, follow these instructions:

Dial: (866) 831-6270 (U.S.); (617) 213-8858 (international)

Passcode: 25099763 (Howard Robin is the host)

An audio replay will also be available shortly following the call through Wednesday, August 19, 2009 and can be accessed by dialing (888) 286-8010 (U.S.); or (617) 801-6888 (international) with a passcode of 26851386.

In the event that any non-GAAP financial measure is discussed on the conference call that is not described in the press release, related information will be made available on the Investor Relations page at the Nektar website as soon as practical after the conclusion of the conference call.

About Nektar

Nektar Therapeutics is a biopharmaceutical company developing novel therapeutics based on its PEGylation and advanced polymer conjugation technology platforms. Nektar's technology and drug development expe
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related biology technology :

1. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
2. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
3. Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting
4. Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIGs Plenary Panel in Vegas
5. Nektar Therapeutics President and CEO Howard Robin to Present at 2007 BIO InvestorForum
6. Nektar Therapeutics to Present at 2007 BMO Capital Markets Focus on Healthcare Conference
7. Nektar Therapeutics President and CEO Howard W. Robin to Present At JPMorgan 26th Annual Healthcare Conference
8. Nektar Appoints Hoyoung Huh, M.D., Ph.D., to Serve on the Companys Board of Directors
9. Nektar Announces Restructuring to Complete Its Transition to a Therapeutics Drug Development Organization
10. West Concludes Agreement with Nektar
11. Nektar to Announce Q1 2008 Financial Results on Wednesday, May 7, 2008, After Close of U.S.-Based Financial Markets

Post Your Comments:

(Date:11/30/2009)...ovember 30 Biopharmaceutical compa...tients have been enrolled in its,multinational reg...is,designed to show reduction in transplant relate...geneic stem cell transplantation with a mismatched...eligible for an allogeneic,stem cell transplantati...

(Date:11/30/2009)..., a leader in providing smart and efficient softwa...Pathology®, evolutionizing work-from-home hist...ard’ software used by 8 of the Top 10 Pharma...ost per slide’ basis. , ... -- PDS has announced another evolution in the his...

(Date:11/30/2009)... , AMSTERDAM, November 30 /PRNewswire-Fir... of scientific, medical and technical products and...base, its comprehensive biomedical,database which ...an 7,000,active, peer reviewed journals. , ...ment of new biomedical,and pharmaceutical insights...

(Date:11/27/2009)...echanised blue dye test alternative is helping b...rance one step closer for pharma-companies. It is ...ine developed by Sepha for use with blister pack...al and global pharma-companies such as Sanofi-Aven...and productivity improvements on the packaging lin...

Breaking Biology Technology:Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM) 2 Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 2 Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 3 Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 2 Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 3 Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 2 Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 3

[0] Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM)[0] Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS [0] Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers [1] Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance

...- Tiens Biotech Group (USA),Inc. ("the Company" or...m ,announced financial results for the fourth qua...Revenue for the fourth quarter of 2007 was $13.3 m...arter of 2006., Net income for the fourth quarter...pared to net income of $5.9 million, or $0.08 per ...

...-. Actavis Group, the,international generic pharma...eived two separate approvals from the U.S. Food & ...ide extended-release tablets (SR). Distribution,of...on Hydrochloride extended-release tablets (SR), av...ent of Wellbutrin SR(R) and are,indicated for the ...

...rch 28 /PRNewswire-FirstCall/,-- Evotec AG (Frankf...results according to IFRS for the year ended Decem...e driven by strong progress in the,Company,s clini..., the,acquisition of Neuro3d, the sale of Evotec T...ment Business (CPD) and the proposed acquisition o...

Tiens Biotech Group (USA) Reports Fourth Quarter and Twelve-Month Results Actavis Receives Approval of Generic Wellbutrin SR(R) and Zyban(R) Tablets in the U.S.Evotec Announces Financial Results for 2007

(Date:11/25/2009)...sistant professors recently received funding from ...research beneficial to understanding the environme...er Blackwood, assistant professor in the Departmen...pport two separate research projects. , His firs...mmunities and Functions from the Leaf to the Lands...

(Date:11/24/2009)... a protein that may help gut bacteria bind to the ...by probiotic producers to identify strains that ar...iotics need to interact with cells lining the gut ... surfaces in the gut they are more likely to stick... Dr Nathalie Juge from the Institute of Food Resea...

(Date:11/24/2009)...s long held secrets of the earth,s history locked ...een very little information on the environments th...ons of years. Now, a team of researchers from nine...the tune of $10 million dollars by the National Sc...things literally. These scientists will drill thr...

Breaking Biology News(10 mins):Kent State University professors focus research on the environment with grants totaling $890,000 2 A sticky solution for identifying effective probiotics 2 LSU gets to the bottom of things -- in Antarctica 2 RES Q Labor Resource Management Ranked as the Top Staff Scheduling System Solution in KLAS 2009 Special Report 56542 1 RES Q Labor Resource Management Ranked as the Top Staff Scheduling System Solution in KLAS 2009 Special Report 56542 2 Go and Good Things Happen with 28BUGABOO 29 28RED 29 56537 1 Go and Good Things Happen with 28BUGABOO 29 28RED 29 56537 2 Go and Good Things Happen with 28BUGABOO 29 28RED 29 56537 3 Go and Good Things Happen with 28BUGABOO 29 28RED 29 56537 4 WomenHeart and P A D Coalition Join Forces to Educate Women about Peripheral Arterial Disease 56532 1 WomenHeart and P A D Coalition Join Forces to Educate Women about Peripheral Arterial Disease 56532 2 WomenHeart and P A D Coalition Join Forces to Educate Women about Peripheral Arterial Disease 56532 3

[0] Kent State University professors focus research on the environment with grants totaling $890,000 [1] A sticky solution for identifying effective probiotics [0] LSU gets to the bottom of things -- in Antarctica

...z. When the larvae of the primitive social insect...uiet pupal stage, she doesnt know if shell arise a...s with Arizona State Universitys social insect res...w light on the development of colonial insects fro...social order of wasps. In a paper highlighted on t...

...itute of Molecular Virology of the GSF National R...rberg/Munich (Helmholtz Association of German Rese...r cellular components whose make-up is changed as ...th colleagues from the Technical University of Mun...sed micro-array technologies micro-arrays are chi...

... how much information we put in our heads" The ans...50,000-250,000 words. And then there are all the l... we grew up in, the time we spilled orange juice o...quadratic equation (for some of us). , So where d...s, the answer would be easy: we would store memori...

Other Biology News:Old developmental pathways spawn revolutionary evolutionary changes 2 Old developmental pathways spawn revolutionary evolutionary changes 3 Prions and retroviruses -- an unholy alliance? 2 A balanced memory network 2

Old developmental pathways spawn revolutionary evolutionary changes Prions and retroviruses -- an unholy alliance?A balanced memory network

Nunc OmniTray from Sigma-Aldrich

...of systems provide fast and reliable scalable auto...eomics and drug development laboratories. Staccato...s; Mini Workstation Series, Application Series and... Staccato Application Series systems use a revolut...

...es Systems provide fast and reliable automation fo... drug development laboratories. Staccato Custom Se...ions, providing solutions that are tailored to the...controlled with either Caliper's time proven CLARA...

Corning Spin-X Centrifuge Tube Filters from Sigma-Aldrich

Biology Products:

Nunc OmniTray from Sigma-Aldrich Staccato iBLOX Modular Tables from Caliper Life Sciences Staccato Custom Series from Caliper Life Sciences Corning Spin-X Centrifuge Tube Filters from Sigma-Aldrich

Nektar to Announce Financial Results for the Second Quarter of 2009 on Tuesday, August 4, 2009, After Close of U.S.-Based Financi...( SAN CARLOS Calif. July 31...)